There is so much information and misinformation circling around the assessment of mold and mycotoxin illness, and what they may indicate or not. In this CME we will look at new and old data regarding testing and clinical assessment, the implications and limitations of that data, and how it fits real world case management. We will look at the other testing and assessment involved in treating the whole person as well as how mold – mycotoxin illness is a core (but not every) factor in a complex chronic illness case.

CME Effective Date:

Part 1: Live Event July 21st, 2026

Part 2:  Live Event August 18th, 2026

CME Expiration Date:

Part 1: Live Event August 21st, 2026

Part 2: Live Event September 18th, 2026

Educational Credits:

Part 1:

2.0 AMA/PRA Category 1 CME Credit™
2.0 Nursing Contact Hours (0.5 Pharmacologic Hours)

Part 2:

2.0 AMA/PRA Category 1 CME Credit™
2.0 Nursing Contact Hours (1.0 Pharmacologic Hours)

Target Audience:

This program is intended for: Physicians (MD, ND, Other), Nurses, Nurse Practitioners, and Other Healthcare professionals

Conflict of Interest Disclosure Policy

Identify, Mitigate, and Disclose Relevant Financial Relationships 

Many healthcare professionals have financial relationships with ineligible companies.  These relationships must not be allowed to influence accredited continuing education.  The Foundation for Care Management (FCM) as the accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships are defined as relevant if the educational content is related to the business lines or products of the ineligible company.  As an accredited provider FCM collects information from planners, faculty and others in control of educational content and conducts an extensive review process.  Financial relationships are identified, reviewed and mitigated.  In some cases. speakers and committee members may be excluded.  All relevant financial relationships are disclosed to the learner below as required by the ACCME

Disclosures:

Planner/Presenter: Dr. Paul Anderson discloses the following: NFH – Vitazan; Science Advisory Board Member, MD Lifespan; Science Advisory Board Member, Priority One; Formulation Advisor.

Reviewers: Kenneth Meyer discloses no financial relationships with any ineligible companies.

Accreditation Statement:

Washington State ND’s: This CME is co-accredited by WANP which allows WA State Category-1 CME Credit for WA Licensed ND’s

In support of improving patient care, this activity has been planned and implemented by the Foundation for Care Management (FCM) and P S Anderson LLC. FCM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Part 1 of this program is approved for 2.0 AMA Category 1 Credits^TM
This program is approved for 2.0 Nursing Contact Hours(0.5 Pharmacologic hours).

Part 2 of this program is approved for 2.0 AMA Category 1 Credits^TM
This program is approved for 2.0 Nursing Contact Hours(1.0 Pharmacologic hours).

Healthcare providers should only claim credit commensurate with the extent of their participation in this activity.